Archive for September, 2003

Genentech's CEO on Big Pharma's Issues

Genentech’s CEO on Big Pharma’s Issues Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research


Click here for reuse options!
Copyright 2003 Biotechblog

Genentech’s CEO on Big Pharma’s Issues

Genentech’s CEO on Big Pharma’s Issues Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research


Click here for reuse options!
Copyright 2003 Biotechblog

FDA's McClellan Calls for More Sharing of Drug R&D Costs

FDA’s McClellan Calls for More Sharing of Drug R&D Costs The U.S. is bearing a disproportionate share of drug research and development costs for medicines used globally, FDA commissioner Mark McClellan said Thursday. He called for more equitable cost sharing and price setting. ‘If we do not find better ways to share the burden of […]


Click here for reuse options!
Copyright 2003 Biotechblog

FDA’s McClellan Calls for More Sharing of Drug R&D Costs

FDA’s McClellan Calls for More Sharing of Drug R&D Costs The U.S. is bearing a disproportionate share of drug research and development costs for medicines used globally, FDA commissioner Mark McClellan said Thursday. He called for more equitable cost sharing and price setting. ‘If we do not find better ways to share the burden of […]


Click here for reuse options!
Copyright 2003 Biotechblog

Drug Development, Genentech Style

Drug Development, Genentech Style “Its promising colon cancer fighter Avastin is a prime example of how the biotech ‘keeps following the science’”


Click here for reuse options!
Copyright 2003 Biotechblog

BIOTECH THAWS OUT

BIOTECH THAWS OUT: “Small drug discovery firms are capitalizing on the positive momentum that’s returned to the market for biotechnology stocks. A dozen have announced plans this quarter to launch initial public stock offerings (IPOs), while nearly as many more hope to raise money through follow-on bids. The upturn, if it persists, may help rescue […]


Click here for reuse options!
Copyright 2003 Biotechblog

Suit targets 13 generic drug makers

Suit targets 13 generic drug makers “Jumping into the escalating legal battle against pharmaceutical manufacturers, Attorney General Thomas F. Reilly planned to file a lawsuit today against 13 generic drug makers, claiming they overcharged the state Medicaid program $50 million for more than 150 medications.”


Click here for reuse options!
Copyright 2003 Biotechblog

Judge Allows Antitrust Case Against Seed Producers

Judge Allows Antitrust Case Against Seed Producers “A federal judge on Friday let proceed an antitrust case that accused the Monsanto Company and other big agricultural seed giants of conspiring to control the world’s market in genetically modified crops.”


Click here for reuse options!
Copyright 2003 Biotechblog

Definitions Impede Stem-Cell Work

Definitions Impede Stem-Cell Work The medical promise of embryonic stem-cell research has been plagued by ethical controversy. Now, an apparent way to get stem cells without destroying human embryos is hung up by federal policy.


Click here for reuse options!
Copyright 2003 Biotechblog

Bioterror Brain Drain

Bioterror Brain Drain “Infectious-disease specialists are following the big bucks to Washington’s new multibillion-dollar program on bioterrorism research�but at what human cost? “


Click here for reuse options!
Copyright 2003 Biotechblog

%d bloggers like this: